Biomarkers and cardiac disease in patients with end-stage renal disease on dialysis

Clinical Biochemist Reviews

Volumn 32, Issue 2, 2011, Pages 115-119

  Hickman, Peter E ^a  

^a The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82055196676     PISSN: 01598090     EISSN: 18380212     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (43)

1. ANZDATA Registry 2009 Report - Deaths. http://www.anzdata.org.au/anzdata/AnzdataReport/32ndReport/Ch03.pdf (Accessed 1 October 2010).
2. Croitoru M, Taegtmeyer H. Spurious rises in troponin T in end-stage renal disease. Lancet 1995;346:974.
3. Apple FS, Sharkey SW, Hoeft P, Skeate R, Voss E, Dahlmeier BA, et al. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis. Am J Kidney Dis 1997;29:399-403.
4. Ooi DS, Veinot JP, Wells GA, House AA. Increased mortality in hemodialyzed patients with elevated serum troponin T: a one-year outcome study. Clin Biochem 1999;32:647-52.
5. Apple FS, Murakami MM, Pearce LA, Herzog CA. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 2004;50: 2279-85.
6. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001;12:1508-15.
7. Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E, et al. Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest 2007;37:350-6.
8. Hickman PE, Koerbin G, Southcott E, Tate J, Dimeski G, Carter A, et al. Newer cardiac troponin I assays have similar performance to troponin T in patients with endstage renal disease. Ann Clin Biochem 2007;44:285-9.
9. Raimann J, Liu L, Tyagi S, Levin NW, Kotanko P. A fresh look at dry weight. Hemodial Int 2008;12: 395-405.
10. Brunkhorst R. Hypervolemia, arterial hypertension and cardiovascular disease: a largely neglected problem in peritoneal dialysis. Clin Nephrol 2008;69:233-8.
11. Converse RL, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992;327:1912-8.
12. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant 1996;11:1277-85.
13. Foley RN, Parfrey PS, Harnett JD. Left ventricular hypertrophy in dialysed patients. Semin Dial 1992;5:34-41.
14. Zoccali C, Benedetto FA, Tripepi G, Mallamaci F. Cardiac consequences of hypertension in hemodialysis patients. Semin Dial 2004;17:299-303.
15. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimburger O, Massy Z. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do the new pieces fit into the uremic puzzle. Clin J Am Soc Nephrol 2008;3:505-21.
16. Bos WJ, Bruin S, van Olden RW, Keur I, Wesseling KH, Westerhof N, et al. Cardiac and hemodynamic effects of hemodialysis and ultrafiltration. Am J Kidney Dis 2000;35:819-26.
17. Zuber M, Steinmann E, Huser B, Ritz R, Thiel G, Brunner F. Incidence of arrhythmias and myocardial ischaemia during haemodialysis and haemofiltration. Nephrol Dial Transplant 1989;4:632-4.
18. Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G. Characteristics of sudden death in hemodialysis patients. Kidney Int 2006;69:2268-73.
19. McIntyre CW. Effects of hemodialysis on cardiac function. Kidney Int 2009;76:371-5.
20. Lilien MR, Groothoff JW. Cardiovascular disease in children with CKD or ESRD. Nat Rev Nephrol 2009;5:229-35.
21. Desai AA, Nissenson A, Chertow GM, Farid M, Singh I, van Oijen MG, et al. The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review. Hemodial Int 2009;13:347-59.
22. Maiorca R, Brunori G, Zubani R, Cancarini GC, Manili L, Camerini C, et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995;10;2295-305.
23. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993;329:1001-6.
24. Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993;44:115-9.
25. Goldwasser P, Michel MA, Collier J, Mittman N, Fein PA, Gusik SA, et al. Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival. Am J Kidney Dis 1993;22:215-25.
26. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469-76.
27. Hickman PE, McGill DA, Talaulikar G, Hiremagalur B, Bromley J, Rahman A, et al. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients. Intern Med J 2009;39:812-8.
28. Dierkes J, Domrose U, Westphal S, Ambrosch A, Bosselmann HP, Neumann KH, et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000;102:1964-9.
29. Khan IA, Wattanasuwan N, Mehta NJ, Tun A, Singh N, Singh HK, et al. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: a two-year outcome analysis. J Am Coll Cardiol 2001;38:991-8.
30. Christenson RH, Azzazy HM. Biochemical markers of the acute coronary syndromes. Clin Chem 1998;44:1855-64.
31. Hetland O, Dickstein K. Cardiac troponins I and T in patients with suspected acute coronary syndrome: a comparative study in a routine setting. Clin Chem 1998;44:1430-6.
32. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941-5.
33. Diris JH, Hackeng CM, Kooman JP, Pinto YM, Hermens WT, van Dieijen-Visser M. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation 2004;109:23-5.
34. Ellis K, Dreisbach AW, Lertora JL. Plasma elimination of cardiac troponin I in end-stage renal disease. South Med J 2001;94:993-6.
35. Katus HA, Haller C, Müller-BardorffM, Scheffold T, Remppis A. Cardiac troponin T in end-stage renal disease patients undergoing chronic maintenance hemodialysis. Clin Chem 1995;41:1201-3.
36. Jaffe AS, Apple FS, Morrow DA, Lindahl B, Katus HA. Being rational about (im)precision: a statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology / American College of Cardiology Foundation / American Heart Association / World Heart Federation Task Force for the definition of myocardial infarction. Clin Chem 2010;56:941-3.
37. Satyan S, Light RP, Agarwal R. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis 2007;50:1009-19.
38. Sun L, Sun Y, Zhao X, Xu C, Chen D, Li L, et al. Predictive role of BNP and NT-proBNP in hemodialysis patients. Nephron Clin Pract 2008;110:c178-84.
39. Svensson M, Gorst-Rasmussen A, Schmidt EB, Jorgensen KA, Christensen JH. NT-pro-BNP is an independent predictor of mortality in patients with endstage renal disease. Clin Nephrol 2009;71:380-6.
40. McGill D, Talaulikar G, Potter JM, Koerbin G, Hickman PE. Over time, high sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure. Clin Chim Acta 2010;411:936-9.
41. Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial troponin T and I assays. Clin Chem 2009;55:101-8.
42. Kavsak PA, MacRae AR, Yerna M-J, Jaffe AS. Analytic and clinical utility of a next-generation highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009;55:573-7.
43. Jacobs LH, van de Kerkhof J, Mingels AM, Kleijnen VW, van der Sande FM, Wodzig WK, et al. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Ann Clin Biochem 2009;46:283-90.